Showing results (181-190 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|December 14, 2019
Medication Discrepancies in Discharge Summaries and Associated Risk Factors for Elderly Patients with Many DrugsGabriella Caleres, Sara Modig, Patrik Midlöv, et al.
Drugs - Real World Outcomes|January 25, 2018
Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical AntipsychoticsMarie-Hélène Lafeuille, Neeta Tandon, Sean Tiggelaar, et al.
Drugs - Real World Outcomes|June 6, 2022
Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival DataJorge Nieva, Karen L Reckamp, Danielle Potter, et al.
Drugs - Real World Outcomes|June 10, 2022
Efficacy and Safety of Long-Term Treatment with Stiripentol in Children and Adults with Drug-Resistant Epilepsies: A Retrospective Cohort Study of 196 PatientsSimona Balestrini, Viola Doccini, Alessandra Boncristiano, et al.
Drugs - Real World Outcomes|June 30, 2022
Treatment Patterns During Major Depressive Episodes Among Patients with Major Depressive Disorder: A Retrospective Database AnalysisRakesh Jain, Sara Higa, Katelyn Keyloun, et al.
Drugs - Real World Outcomes|July 2, 2022
The Use of a Network Analysis to Identify Associations and Temporal Patterns Among Non-communicable Diseases in Japan Based on a Large Medical Claims DatabaseShingo Higa, Kazutaka Nozawa, Yusuke Karasawa, et al.
Drugs - Real World Outcomes|July 6, 2022
Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort StudyMaximilian Wechsler, Robert H G Schwinger
Drugs - Real World Outcomes|January 13, 2021
The Xyrem® (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017Michael J Strunc, Jed Black, Prasheel Lillaney, et al.
Drugs - Real World Outcomes|May 27, 2021
Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)Charles R Sims, Adam M Bressler, Donald R Graham, et al.
Drugs - Real World Outcomes|February 11, 2020
Adverse Drug Reactions in Selected Wards of the Yangon General Hospital and Yangon Specialty Hospital During the First Quarter of 2019: An Active Pharmacovigilance Study in MyanmarLwin Moe May, Albert Figueras, Ye Htut Linn, et al.
Pageof 55